In accord, most of the MLL fusion-mediated leukemia patient samples in the MILE study with high HOXA9 expression expressed BCL2 and SOX4 at high levels (Figure 5—figure supplement 2B; Haferlach et al., 2010). The gene discussed is KMT2A; the disease is leukemia.